These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1198 related articles for article (PubMed ID: 25996938)
1. Association of serum level of growth differentiation factor 15 with liver cirrhosis and hepatocellular carcinoma. Liu X; Chi X; Gong Q; Gao L; Niu Y; Chi X; Cheng M; Si Y; Wang M; Zhong J; Niu J; Yang W PLoS One; 2015; 10(5):e0127518. PubMed ID: 25996938 [TBL] [Abstract][Full Text] [Related]
2. Serum DKK1 as a protein biomarker for the diagnosis of hepatocellular carcinoma: a large-scale, multicentre study. Shen Q; Fan J; Yang XR; Tan Y; Zhao W; Xu Y; Wang N; Niu Y; Wu Z; Zhou J; Qiu SJ; Shi YH; Yu B; Tang N; Chu W; Wang M; Wu J; Zhang Z; Yang S; Gu J; Wang H; Qin W Lancet Oncol; 2012 Aug; 13(8):817-26. PubMed ID: 22738799 [TBL] [Abstract][Full Text] [Related]
3. Des-gamma-carboxyprothrombin, alpha-fetoprotein and AFP-L3 in patients with chronic hepatitis, cirrhosis and hepatocellular carcinoma. Durazo FA; Blatt LM; Corey WG; Lin JH; Han S; Saab S; Busuttil RW; Tong MJ J Gastroenterol Hepatol; 2008 Oct; 23(10):1541-8. PubMed ID: 18422961 [TBL] [Abstract][Full Text] [Related]
4. Usefulness of alpha-fetoprotein in the diagnosis of hepatocellular carcinoma. Soresi M; Magliarisi C; Campagna P; Leto G; Bonfissuto G; Riili A; Carroccio A; Sesti R; Tripi S; Montalto G Anticancer Res; 2003; 23(2C):1747-53. PubMed ID: 12820452 [TBL] [Abstract][Full Text] [Related]
5. Evaluation of Serum GDF15, AFP, and PIVKA-II as Diagnostic Markers for HBV-Associated Hepatocellular Carcinoma. Chen J; Tang D; Xu C; Niu Z; Li H; Li Y; Zhang P Lab Med; 2021 Jul; 52(4):381-389. PubMed ID: 33159511 [TBL] [Abstract][Full Text] [Related]
6. Serum VEGF as a tumor marker in patients with HCV-related liver cirrhosis and hepatocellular carcinoma. Mukozu T; Nagai H; Matsui D; Kanekawa T; Sumino Y Anticancer Res; 2013 Mar; 33(3):1013-21. PubMed ID: 23482775 [TBL] [Abstract][Full Text] [Related]
7. [Usefulness of serum alpha-fetoprotein (AFP) as a marker for hepatocellular carcinoma (HCC) in hepatitis C virus related cirrhosis: analysis of the factors influencing AFP elevation without HCC development]. Kim KA; Lee JS; Jung ES; Kim JY; Bae WK; Kim NH; Moon YS Korean J Gastroenterol; 2006 Nov; 48(5):321-6. PubMed ID: 17132920 [TBL] [Abstract][Full Text] [Related]
8. Evaluation of serum clusterin as a surveillance tool for human hepatocellular carcinoma with hepatitis B virus related cirrhosis. Wang Y; Liu YH; Mai SJ; He LJ; Liao YJ; Deng HX; Guan XY; Zeng YX; Kung HF; Xie D J Gastroenterol Hepatol; 2010 Jun; 25(6):1123-8. PubMed ID: 20594228 [TBL] [Abstract][Full Text] [Related]
9. [Serum anti-Ku86: a potential biomarker for early detection of hepatocellular carcinoma]. Chu L; Zhang X; Wang G; Zhou W; Du Z; Liu A; Zhao H Zhonghua Zhong Liu Za Zhi; 2014 Feb; 36(2):123-7. PubMed ID: 24796461 [TBL] [Abstract][Full Text] [Related]
10. Influence of hepatitis C virus infection on circulating levels of sICAM-1 and VEGF in patients with hepatitis C and hepatocellular carcinoma (HCC) and their role in enhancing detection of HCC. Helaly GF; Abou Shamaa LA Egypt J Immunol; 2006; 13(1):27-38. PubMed ID: 17974148 [TBL] [Abstract][Full Text] [Related]
11. Diagnostic role of serum glypican-3 in differentiating hepatocellular carcinoma from non-malignant chronic liver disease and other liver cancers. Tangkijvanich P; Chanmee T; Komtong S; Mahachai V; Wisedopas N; Pothacharoen P; Kongtawelert P J Gastroenterol Hepatol; 2010 Jan; 25(1):129-37. PubMed ID: 19793164 [TBL] [Abstract][Full Text] [Related]
12. Alpha-fetoprotein as a tumor marker in hepatocellular carcinoma: investigations in south Indian subjects with hepatotropic virus and aflatoxin etiologies. Murugavel KG; Mathews S; Jayanthi V; Shankar EM; Hari R; Surendran R; Vengatesan A; Raghuram K; Rajasambandam P; Murali A; Srinivas U; Palaniswamy KR; Pugazhendhi T; Thyagarajan SP Int J Infect Dis; 2008 Nov; 12(6):e71-6. PubMed ID: 18658001 [TBL] [Abstract][Full Text] [Related]
13. Hepatocellular carcinoma and its early detection by AFP testing in Mongolia. Oyunsuren T; Sanduijav R; Davaadorj D; Nansalmaa D Asian Pac J Cancer Prev; 2006; 7(3):460-2. PubMed ID: 17059345 [TBL] [Abstract][Full Text] [Related]
14. Serum biomarkers for early detection of hepatocellular carcinoma associated with HCV infection in egyptian patients. Zekri AR; Youssef AS; Bakr YM; Gabr RM; El-Rouby MN; Hammad I; Ahmed EA; Marzouk HA; Nabil MM; Hamed HA; Aly YH; Zachariah KS; Esmat G Asian Pac J Cancer Prev; 2015; 16(3):1281-7. PubMed ID: 25735368 [TBL] [Abstract][Full Text] [Related]
15. Alpha-fetoprotein still is a valuable diagnostic and prognosis predicting biomarker in hepatitis B virus infection-related hepatocellular carcinoma. Yao M; Zhao J; Lu F Oncotarget; 2016 Jan; 7(4):3702-8. PubMed ID: 26784252 [TBL] [Abstract][Full Text] [Related]
16. Development and potential application of a simultaneous multiplex assay of Golgi protein 73 and alpha-fetoprotein for hepatocellular carcinoma diagnosis. Xiao J; Long F; Peng T; Hu LB; Cai H; Chen R; Chen WL Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3302-3310. PubMed ID: 31081083 [TBL] [Abstract][Full Text] [Related]
17. Feasibility of α-fetoprotein as a diagnostic tool for hepatocellular carcinoma in Korea. Ahn DG; Kim HJ; Kang H; Lee HW; Bae SH; Lee JH; Paik YH; Lee JS Korean J Intern Med; 2016 Jan; 31(1):46-53. PubMed ID: 26767857 [TBL] [Abstract][Full Text] [Related]
18. Determinants of alpha-fetoprotein levels in patients with hepatocellular carcinoma: implications for its clinical use. Giannini EG; Sammito G; Farinati F; Ciccarese F; Pecorelli A; Rapaccini GL; Di Marco M; Caturelli E; Zoli M; Borzio F; Cabibbo G; Felder M; Gasbarrini A; Sacco R; Foschi FG; Missale G; Morisco F; Svegliati Baroni G; Virdone R; Trevisani F; Cancer; 2014 Jul; 120(14):2150-7. PubMed ID: 24723129 [TBL] [Abstract][Full Text] [Related]
19. [Detection and evaluation of serum GP73, a resident Golgi glycoprotein, as a marker in diagnosis of hepatocellular carcinoma]. Zhao XY; Li N; Ding HG; Jiang FF Zhonghua Zhong Liu Za Zhi; 2010 Dec; 32(12):943-5. PubMed ID: 21223806 [TBL] [Abstract][Full Text] [Related]
20. Inter-alpha-trypsin inhibitor heavy chain H4 as a diagnostic and prognostic indicator in patients with hepatitis B virus-associated hepatocellular carcinoma. Noh CK; Kim SS; Kim DK; Lee HY; Cho HJ; Yoon SY; Lee GH; Hyun SA; Kim YJ; Kim HJ; Hwang JA; Ahn SJ; Shin SJ; Lee KM; Yoo BM; Cho SW; Cheong JY Clin Biochem; 2014 Sep; 47(13-14):1257-61. PubMed ID: 24836184 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]